MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments

被引：0
|
作者：
Heleen Scheerens
Zheng Su
Bryan Irving
Michael J Townsend
Yanan Zheng
Eric Stefanich
Vishala Chindalore
Clifton O Bingham
John C Davis
机构：
[1] Genentech Research and Early Development,Allergy and Clinical Immunology
[2] 1 DNA Way,undefined
[3] Pinnacle Research Center Anniston Medical Clinic PC,undefined
[4] Johns Hopkins University,undefined
来源：
Arthritis Research & Therapy | / 13卷
关键词：
rheumatoid arthritis; pharmacodynamics; phase I; antibody;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Nanki, Toshihiro
    Umehara, Hisanori
    Yasuda, Nobuyuki
    Tago, Fumitoshi
    Kitahara, Yasumi
    Kawakubo, Makoto
    Torii, Kentaro
    Hojo, Seiichiro
    Kawano, Tetsu
    Imai, Toshio
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (04) : 587 - 595
  • [42] Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patients
    Choy, EHS
    Connolly, DJA
    Rapson, N
    Jeal, S
    Brown, JCC
    Kingsley, GH
    Panayi, GS
    Johnston, JM
    RHEUMATOLOGY, 2000, 39 (10) : 1139 - 1146
  • [43] LACK OF EFFECT OF SECUKINUMAB TREATMENT ON THE LIPID PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE II STUDY
    Durez, P.
    Genovese, M.
    Kellner, H.
    Codding, C.
    Ligozio, G.
    Richards, H.
    Escrig, C.
    Mpofu, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 194 - 195
  • [44] Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
    Genovese, Mark C.
    Jarosova, Katerina
    Cieslak, Dorota
    Alper, Jeffrey
    Kivitz, Alan
    Hough, Douglas R.
    Maes, Peter
    Pineda, Lilia
    Chen, Mindy
    Zaidi, Farrukh
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (07) : 1703 - 1710
  • [45] Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study
    Stohl, William
    Merrill, Joan T.
    McKay, James D.
    Lisse, Jeffrey R.
    Zhong, Z. John
    Freimuth, William W.
    Genovese, Mark C.
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (05) : 579 - 589
  • [46] TREATMENT OF ACTIVE RHEUMATOID-ARTHRITIS WITH SLOW INTRAVENOUS INJECTIONS OF THYMOPENTIN - A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY
    MALAISE, MG
    FRANCHIMONT, P
    BACHANDERSEN, R
    GERBER, H
    STOCKER, H
    HAUWAERT, C
    DANNESKIOLDSAMSOE, B
    GROSS, D
    GERSCHPACHER, H
    BOLLA, K
    LANCET, 1985, 1 (8433): : 832 - 836
  • [47] Clinical Pharmacology of an Anti-CD4 Monoclonal Antibody with Enhanced FcRn Binding Affinity in a Phase I Study for Rheumatoid Arthritis
    Scheerens, Heleen
    Zheng, Yanan
    Davis, John
    Su, Zheng
    Deng, Rong
    Fischer, Sally
    Woods, Cynthia
    Fielder, Paul
    Stefanich, Eric
    CLINICAL IMMUNOLOGY, 2010, 135 : S85 - S85
  • [48] ITOLIZUMAB, A HUMAN ANTI-CD6 MONOCLONAL ANTIBODY, FOR TREATMENT OF RHEUMATOID ARTHRITIS: RESULTS OF A RANDOMIZED, PLACEBO CONTROLLED, PHASE 2 STUDY
    Chopra, A.
    Srikantiah, C.
    Cg, P.
    Montero, E.
    Melarkode, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 69 - 70
  • [49] Vunakizumab in Patients with Active Psoriatic Arthritis: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study
    Zou, Hejian
    Wan, Weiguo
    Xue, Yu
    Sun, Lingyun
    Zhang, Ning
    Chen, Haiying
    Shi, Xiaofei
    Liu, Shengyun
    Chen, Lin
    Ma, Xinmei
    Wei, Hua
    Jiang, Zhenyu
    Li, Xiaomei
    Fan, Hongtao
    Li, Hongbin
    Li, Jingyang
    Wu, Rui
    Shi, Guixiu
    Zhu, Jing
    Kong, Xiaodan
    Lu, Yuewu
    Cui, Xiaojing
    Zheng, Qianning
    Bai, Xiaoyan
    Dong, Guangchao
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5240 - 5242
  • [50] Safety of efalizumab in patients with psoriatic arthritis: Results of a phase II, randomized, double-blind, placebo-controlled study
    Papp, K
    Mease, P
    Garovoy, M
    Zhang, D
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P156 - P156
12345